These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 20453196)

  • 1. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.
    Ahmadiyeh N; Pomerantz MM; Grisanzio C; Herman P; Jia L; Almendro V; He HH; Brown M; Liu XS; Davis M; Caswell JL; Beckwith CA; Hills A; Macconaill L; Coetzee GA; Regan MM; Freedman ML
    Proc Natl Acad Sci U S A; 2010 May; 107(21):9742-6. PubMed ID: 20453196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus.
    Xiang JF; Yin QF; Chen T; Zhang Y; Zhang XO; Wu Z; Zhang S; Wang HB; Ge J; Lu X; Yang L; Chen LL
    Cell Res; 2014 May; 24(5):513-31. PubMed ID: 24662484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-range enhancers on 8q24 regulate c-Myc.
    Sotelo J; Esposito D; Duhagon MA; Banfield K; Mehalko J; Liao H; Stephens RM; Harris TJ; Munroe DJ; Wu X
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3001-5. PubMed ID: 20133699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
    Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
    PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.
    Wasserman NF; Aneas I; Nobrega MA
    Genome Res; 2010 Sep; 20(9):1191-7. PubMed ID: 20627891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.
    Ling H; Spizzo R; Atlasi Y; Nicoloso M; Shimizu M; Redis RS; Nishida N; Gafà R; Song J; Guo Z; Ivan C; Barbarotto E; De Vries I; Zhang X; Ferracin M; Churchman M; van Galen JF; Beverloo BH; Shariati M; Haderk F; Estecio MR; Garcia-Manero G; Patijn GA; Gotley DC; Bhardwaj V; Shureiqi I; Sen S; Multani AS; Welsh J; Yamamoto K; Taniguchi I; Song MA; Gallinger S; Casey G; Thibodeau SN; Le Marchand L; Tiirikainen M; Mani SA; Zhang W; Davuluri RV; Mimori K; Mori M; Sieuwerts AM; Martens JW; Tomlinson I; Negrini M; Berindan-Neagoe I; Foekens JA; Hamilton SR; Lanza G; Kopetz S; Fodde R; Calin GA
    Genome Res; 2013 Sep; 23(9):1446-61. PubMed ID: 23796952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the Links between MYC and 3D Chromatin Structure and Epigenetics Regulation: Implications for Cancer Therapy.
    Amjadi-Moheb F; Paniri A; Akhavan-Niaki H
    Cancer Res; 2021 Apr; 81(8):1925-1936. PubMed ID: 33472888
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome.
    Du M; Yuan T; Schilter KF; Dittmar RL; Mackinnon A; Huang X; Tschannen M; Worthey E; Jacob H; Xia S; Gao J; Tillmans L; Lu Y; Liu P; Thibodeau SN; Wang L
    Hum Mol Genet; 2015 Jan; 24(1):154-66. PubMed ID: 25149474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue.
    Prokunina-Olsson L; Hall JL
    Mol Cancer; 2009 Nov; 8():96. PubMed ID: 19895682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.
    Guan Y; Kuo WL; Stilwell JL; Takano H; Lapuk AV; Fridlyand J; Mao JH; Yu M; Miller MA; Santos JL; Kalloger SE; Carlson JW; Ginzinger DG; Celniker SE; Mills GB; Huntsman DG; Gray JW
    Clin Cancer Res; 2007 Oct; 13(19):5745-55. PubMed ID: 17908964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-distance interaction of the integrated HPV fragment with MYC gene and 8q24.22 region upregulating the allele-specific MYC expression in HeLa cells.
    Shen C; Liu Y; Shi S; Zhang R; Zhang T; Xu Q; Zhu P; Chen X; Lu F
    Int J Cancer; 2017 Aug; 141(3):540-548. PubMed ID: 28470669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
    Pomerantz MM; Ahmadiyeh N; Jia L; Herman P; Verzi MP; Doddapaneni H; Beckwith CA; Chan JA; Hills A; Davis M; Yao K; Kehoe SM; Lenz HJ; Haiman CA; Yan C; Henderson BE; Frenkel B; Barretina J; Bass A; Tabernero J; Baselga J; Regan MM; Manak JR; Shivdasani R; Coetzee GA; Freedman ML
    Nat Genet; 2009 Aug; 41(8):882-4. PubMed ID: 19561607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state.
    Poli V; Fagnocchi L; Fasciani A; Cherubini A; Mazzoleni S; Ferrillo S; Miluzio A; Gaudioso G; Vaira V; Turdo A; Gaggianesi M; Chinnici A; Lipari E; Bicciato S; Bosari S; Todaro M; Zippo A
    Nat Commun; 2018 Mar; 9(1):1024. PubMed ID: 29523784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells.
    Wright JB; Brown SJ; Cole MD
    Mol Cell Biol; 2010 Mar; 30(6):1411-20. PubMed ID: 20065031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
    Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
    Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
    Pomerantz MM; Beckwith CA; Regan MM; Wyman SK; Petrovics G; Chen Y; Hawksworth DJ; Schumacher FR; Mucci L; Penney KL; Stampfer MJ; Chan JA; Ardlie KG; Fritz BR; Parkin RK; Lin DW; Dyke M; Herman P; Lee S; Oh WK; Kantoff PW; Tewari M; McLeod DG; Srivastava S; Freedman ML
    Cancer Res; 2009 Jul; 69(13):5568-74. PubMed ID: 19549893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
    Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
    Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice deficient of
    Dave K; Sur I; Yan J; Zhang J; Kaasinen E; Zhong F; Blaas L; Li X; Kharazi S; Gustafsson C; De Paepe A; Månsson R; Taipale J
    Elife; 2017 Jun; 6():. PubMed ID: 28583252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hold the MYCrophone: MYC Invades Enhancers to Control Cancer-Type Gene Programs.
    MacPherson-Hawthorne K; Sears RC
    Cancer Res; 2024 Jul; 84(14):2227-2228. PubMed ID: 38695859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus.
    Cai M; Kim S; Wang K; Farnham PJ; Coetzee GA; Lu W
    Sci Rep; 2016 Mar; 6():22462. PubMed ID: 26934861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.